ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,065.60
      -0.08%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.715
      0.61%
      Bitcoin
      66,857.54
      2.48%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Invivyd Inc (IVVD)

      7. Invivyd Inc (IVVD) News

      IVVD

      Invivyd (IVVD)

      Invivyd Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IVVD
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/16/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IVVDInvivyd Inc
      05/13/20244:01PMGlobeNewswire Inc.Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:IVVDInvivyd Inc
      05/09/20244:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IVVDInvivyd Inc
      05/09/20244:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
      05/09/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/09/20244:01PMGlobeNewswire Inc.Invivyd Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
      05/07/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      05/07/20247:30AMGlobeNewswire Inc.Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA FeedbackNASDAQ:IVVDInvivyd Inc
      05/02/20245:13PMGlobeNewswire Inc.Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business HighlightsNASDAQ:IVVDInvivyd Inc
      04/30/20247:30AMGlobeNewswire Inc.Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash PositionNASDAQ:IVVDInvivyd Inc
      04/15/20247:30AMGlobeNewswire Inc.Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™NASDAQ:IVVDInvivyd Inc
      04/12/20247:30AMGlobeNewswire Inc.Invivyd Announces CEO TransitionNASDAQ:IVVDInvivyd Inc
      04/04/20244:01PMGlobeNewswire Inc.Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 MillionNASDAQ:IVVDInvivyd Inc
      03/28/20247:00AMGlobeNewswire Inc.Invivyd Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
      03/22/20243:28PMGlobeNewswire Inc.Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical TrialNASDAQ:IVVDInvivyd Inc
      03/22/20243:04PMGlobeNewswire Inc.Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19NASDAQ:IVVDInvivyd Inc
      02/12/20244:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IVVDInvivyd Inc
      02/09/20244:47PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IVVDInvivyd Inc
      02/09/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      02/05/20244:02PMGlobeNewswire Inc.Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IVVDInvivyd Inc
      01/26/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      01/26/20244:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      01/08/20247:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      01/03/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      01/03/20247:00AMGlobeNewswire Inc.Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and AdolescentsNASDAQ:IVVDInvivyd Inc
      12/22/20234:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
      12/22/20234:51PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IVVDInvivyd Inc
      12/20/20234:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
      12/20/20234:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
       Showing the most relevant articles for your search:NASDAQ:IVVD